Express Scripts Ethical Violations: Billing, Privacy & Sales
This paper analyzes the ethical failures of Express Scripts, a pharmaceutical benefits management company founded in 1986. Despite steady earnings growth, the company became embroiled in several serious ethical controversies, including encouraging physicians to switch patients to generic drugs while billing insurers at brand-name rates, targeting senior citizens with misleading mail-order drug programs, engaging in unauthorized billing practices, and failing to protect millions of customers' personal health records from hackers. The paper argues that a corporate culture focused exclusively on profit — reinforced by lavish executive compensation — allowed these violations to persist, resulting in multi-state legal settlements and widespread consumer harm.
- Introduction: Framing ethical failures through executive pay context
- Express Scripts Company Overview: Company history, model, and earnings growth
- Drug Switching and Billing Fraud: Multi-state lawsuit over generic drug billing scheme
- Predatory Sales Tactics Targeting Senior Citizens: Mail-order program complaints targeting elderly customers
- Unauthorized Billing and Customer Complaints: Unauthorized charges and billing misconduct examples
- Data Security Failure and Extortion: Hackers breach records; extortion attempt goes undetected
- Conclusion: Pattern of profit-driven misconduct likely to continue
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Uses concrete, documented incidents — the $9.5 million multi-state settlement, the Better Business Bureau advisory, and the extortion/data breach — as evidence rather than relying on general claims.
- Incorporates a direct customer complaint quotation that gives a human dimension to abstract billing misconduct, making the ethical argument more persuasive.
- Connects executive compensation data to corporate behavior, framing lavish pay packages as both a symptom and driver of the ethical culture being criticized.
Key academic technique demonstrated
The paper uses a pattern-of-conduct argument: rather than treating each ethical lapse as an isolated event, it builds a cumulative case that the violations share a common root cause — profit maximization at the expense of customers. This technique is effective in ethics essays because it shifts the burden from proving intent in any single incident to demonstrating a systemic failure of corporate governance.
Structure breakdown
The paper opens with a framing introduction linking executive compensation to ethical culture, then provides a brief company overview for context. Four distinct ethical issues are each given their own analytical section. A short synthesis paragraph before the conclusion ties the incidents together, and the conclusion restates the central argument and offers a predictive warning about future misconduct. This issue-by-issue structure keeps evidence organized and easy to follow.
Introduction
Over the last several years, the issue of ethical business practices has been consistently brought to the forefront. Part of the reason for this is the various loopholes that many corporate executives have exploited to maximize their profits, utilizing a number of questionable tactics to achieve their objectives. A telling example can be found in the case of Express Scripts, a company that wrestled with a number of serious ethical controversies while simultaneously awarding its CEO a compensation increase — from $340 thousand in 2008 to $10.6 million in 2009 — with a total compensation package valued at $34 million (Brin). This is significant because it underscores how, during a period of documented unethical business practices, the company was rewarding its officers with lavish pay packages. Such a standard within the organization effectively incentivized unscrupulous behavior as a means of improving the bottom line.
Examining the business model of Express Scripts and the various ethical issues the company faced provides the clearest insight into how these practices were used to drive profits at the expense of customers and the public interest.
Express Scripts Company Overview
Founded in 1986, Express Scripts is a pharmaceutical benefits management company whose primary objective is to provide consumers with affordable solutions for purchasing prescription drugs. Based in Saint Louis, Missouri, the company achieves this goal through a database service that works in conjunction with pharmacies, healthcare providers, and HMOs. The service provides detailed information on prescription drugs, available generics, cost-saving opportunities, and a wide variety of drug options. This information is available to members of health organizations that maintain an alliance with Express Scripts ("About Us"). The platform is designed to give health organizations an effective way to manage their operations while also supplying consumers with information about prescription and generic drug options.
When examining the company's overall earnings trend, it is clear that revenues rose dramatically between 2004 and 2009 — growing from $0.98 per share in 2004 to $3.58 in 2009 — with analysts at the time estimating earnings of $4.95 for the following year ("Earnings Estimates").
Drug Switching and Billing Fraud
Despite the company's stated dedication to helping clients and consumers, Express Scripts became consumed with increasing its bottom line at all costs. This pattern is evident in four distinct incidents that occurred over a period of several years: billing fraud through drug switching, predatory sales tactics targeting senior citizens, unauthorized billing practices, and improper handling of customer information.
The drug switching controversy is perhaps the most egregious example. Express Scripts encouraged healthcare providers and physicians to intentionally write prescriptions for generic drugs rather than the more expensive, patent-protected brand-name equivalents. The stated purpose was to generate cost savings for plan members. However, the company did not pass these savings on to customers; instead, it recorded the savings as profit and billed clients at the higher rate for the brand-name drugs (Edward). As a result, 28 states sued the company for this ethical and legal violation, and Express Scripts ultimately settled with multiple state attorneys general for $9.5 million.
Washington State Attorney General Rob McKenna commented on the settlement: "Doctors and patients need to be told the truth about how their prescription drug choices will affect their health and their pocketbook. Today's settlement with Express Scripts is part of our ongoing efforts to ensure that pharmacy benefit managers conform to the ethical business standards that all of us deserve and expect" ("Attorney General McKenna Announces Express Scripts to Pay $9.5 Million"). The settlement underscores a troubling pattern: the company had abandoned its focus on providing accurate and cost-effective service in favor of profit maximization. The willingness to settle — rather than contest the charges at trial — strongly suggests the company knew its conduct was indefensible.
Conclusion
Express Scripts engaged in a pattern of activities that brought its overall ethics into serious question. The most notable incidents include billing fraud through drug switching, predatory sales tactics aimed at senior citizens, unauthorized billing practices, and the mishandling of customer data. These events are not isolated; their consistency points to a corporate culture in which top executives incentivized unethical conduct as a means of maximizing profit. When caught, the company paid relatively modest fines and returned to business as usual — a dynamic that offered no meaningful deterrent against future violations.
As long as the financial penalties for misconduct remain smaller than the profits derived from it, there is little incentive for Express Scripts — or any similarly positioned company — to place customer interests ahead of shareholder returns. The regulatory and competitive environment surrounding pharmacy benefit managers will need to evolve significantly if such patterns of misconduct are to be reversed. Until genuine accountability mechanisms are in place, these issues are likely to worsen before they improve. Only at that point may management begin to recognize that putting the customer first is not merely an ethical obligation, but also sound business practice.
Always verify citation format against your institution’s current style guide requirements.